Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for medical cannabis in Germany. The guidance issued by the KBV and GKV-Spitzenverband represents an important step forward by providing greater practical direction for the prescribing of standardized…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
